Tomoki Nakajima

1.7k total citations
45 papers, 1.3k citations indexed

About

Tomoki Nakajima is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Tomoki Nakajima has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Epidemiology and 11 papers in Oncology. Recurrent topics in Tomoki Nakajima's work include Cancer-related Molecular Pathways (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Tomoki Nakajima is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Tomoki Nakajima collaborates with scholars based in Japan. Tomoki Nakajima's co-authors include Takeshi Okanoue, Yoshito Itoh, Tatsuo Katagishi, Keizo Kagawa, Hiroyuki Kimura, Masahito Minami, Hidetaka Takashima, Michihisa Moriguchi, Taichiro Nishikawa and Kohichiroh Yasui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Cancer.

In The Last Decade

Tomoki Nakajima

42 papers receiving 1.2k citations

Peers

Tomoki Nakajima
Chang Yeob Han South Korea
Lily Dara United States
Tomoki Nakajima
Citations per year, relative to Tomoki Nakajima Tomoki Nakajima (= 1×) peers Laura Conde de la Rosa

Countries citing papers authored by Tomoki Nakajima

Since Specialization
Citations

This map shows the geographic impact of Tomoki Nakajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoki Nakajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoki Nakajima more than expected).

Fields of papers citing papers by Tomoki Nakajima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoki Nakajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoki Nakajima. The network helps show where Tomoki Nakajima may publish in the future.

Co-authorship network of co-authors of Tomoki Nakajima

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoki Nakajima. A scholar is included among the top collaborators of Tomoki Nakajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoki Nakajima. Tomoki Nakajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakajima, Tomoki, et al.. (2025). Co-Cr-W-Pt alloys with high X-ray visibility for next-generation balloon-expandable stents. Materials Science and Engineering A. 931. 148216–148216.
2.
Nakajima, Tomoki, et al.. (2025). Formation of unique heterogeneous microstructure in biomedical Co-Cr-W-Ni-C alloys by mechanical milling and heat treatment processes. Journal of Alloys and Compounds. 1036. 181631–181631. 1 indexed citations
3.
Nakajima, Tomoki, et al.. (2012). Age is a Negative, and Visceral Fat Accumulation is a Positive, Contributor to Hepatic Steatosis, Regardless of the Fibrosis Progression in Non-alcoholic Fatty Liver Disease. Journal of Gastroenterology and Hepatology Research. 1(11). 315–319. 7 indexed citations
4.
Jo, Masayasu, Taichiro Nishikawa, Tomoki Nakajima, et al.. (2011). Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma. Journal of Gastroenterology. 46(6). 809–821. 40 indexed citations
5.
Nishikawa, Taichiro, Tomoki Nakajima, Tatsuo Katagishi, et al.. (2009). Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation. Liver International. 29(6). 846–856. 30 indexed citations
6.
Umemura, Atsushi, Yoshito Itoh, Katsuhiko Itoh, et al.. (2007). Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma. Hepatology. 47(2). 493–502. 49 indexed citations
8.
Harano, Yuichi, Kohichiroh Yasui, Tetsuya Toyama, et al.. (2006). Fenofibrate, a peroxisome proliferator‐activated receptor α agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver. Liver International. 26(5). 613–620. 131 indexed citations
9.
Mori, Kojiro, Masahito Minami, Tomoki Nakajima, et al.. (2006). Prediction of Breakthrough Hepatitis due to Lamivudine-Resistant Hepatitis B Virus by a Sensitive Semiquantitative Assay Using Peptide Nucleic Acids. Intervirology. 49(5). 274–280. 5 indexed citations
10.
Nishikawa, Taichiro, Tomoki Nakajima, Michihisa Moriguchi, et al.. (2005). A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. Journal of Hepatology. 44(6). 1074–1082. 146 indexed citations
11.
Takashima, Hidetaka, Tomoki Nakajima, Michihisa Moriguchi, et al.. (2005). In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma. Liver International. 25(1). 77–84. 26 indexed citations
12.
Minami, Masahito, Kojiro Mori, Hidetaka Takashima, et al.. (2005). Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis. Oncogene. 24(27). 4340–4348. 66 indexed citations
13.
Nakajima, Tomoki, Tatsuo Katagishi, Michihisa Moriguchi, et al.. (2004). Tumor size-independence of telomere length indicates an aggressive feature of HCC. Biochemical and Biophysical Research Communications. 325(4). 1131–1135. 8 indexed citations
14.
Nakajima, Tomoki. (2004). Recurrence of hepatocellular carcinoma with rapid growth after spontaneous regression. World Journal of Gastroenterology. 10(22). 3385–3385. 11 indexed citations
15.
Moriguchi, Michihisa, Tomoki Nakajima, Tadashi Watanabe, et al.. (2002). The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin‐8 production. International Journal of Cancer. 102(5). 445–452. 83 indexed citations
16.
Nakajima, Tomoki, Keizo Kagawa, Hiroyuki Kimura, et al.. (1999). Novel Formula for Cell Kinetics in Xenograft Model of Hepatocellular Carcinoma Using Histologically Calculable Parameters. Experimental Cell Research. 246(2). 412–420. 6 indexed citations
17.
Kagawa, Keizo, Tomoki Nakajima, Tatsuo Katagishi, et al.. (1996). Cytogenetic analyses of hepatocellular carcinoma by in situ hybridization with a chromosome-specific DNA probe. Cancer. 77(2). 271–277. 18 indexed citations
18.
Nakajima, Tomoki, Keizo Kagawa, Tatsuo Katagishi, et al.. (1995). Identification of apoptotic hepatocytes in situ in rat liver after lead nitrate administration. Journal of Gastroenterology. 30(6). 725–730. 11 indexed citations
19.
Kimura, Hiroyuki, Keizo Kagawa, Tomoki Nakajima, et al.. (1993). Immunohistochemical study on p53 expression in hepatocellular carcinomas.. Kanzo. 34(8). 606–610. 6 indexed citations
20.
Yamaguchi, K, et al.. (1985). Pneumatosis cystoides intestinalis and trichloroethylene exposure.. PubMed. 80(10). 753–7. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026